- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Medical use of Cannabis is permitted: Centre tells Delhi HC
New Delhi: The use of cannabis is not completely banned in the country as its medical and scientific use is allowed under the law, the Centre has told the Delhi High Court which, on Monday refused to advance the date of hearing of the plea seeking to legalise its use on various grounds including medicinal purposes.
The bench headed by Justice Rajiv Shakhder refused to allow the early hearing application by the petitioner Great Legalisation Movement India Trust which contended that there were reports to suggest that cannabinoids helped in countering the impact of COVID-19.
Also Read:Cannabis use in type 1 diabetes may lead to ketosis, be wary of misdiagnosis: Study
"Looking at the board position, the application can't be entertained at this junction. We are trying to do whatever is possible," the bench, also comprising Justice Talwant Singh told counsel for the petitioner, advocate Abhishek Avadhani.
The petition, which is listed for further hearing in March, has challenged provisions of the Narcotic Drugs and Psychotropic Substances (NDPS) Act which prohibit the use of cannabis and has contended that the drug has medicinal and industrial benefits.
The petitioner has sought directions to the central government to frame rules permitting and regulating use of cannabis, especially for medicinal purposes.
In its affidavit filed last year, the Centre urged the court to dismiss the petition with costs and claimed that it has "adopted a balanced approach on cannabis" by empowering the State governments to "permit, control and regulate the cultivation of any cannabis plant, production, manufacture, possession, transport, import inter-state, export inter-state, sale, purchase, consumption or use of cannabis (excluding charas) for medical, scientific and industrial purposes".
The central government stated that the present legal framework regulating the usage of cannabis did not violate Articles 14 (right to equality), 19(1)(g) [freedom of trade], 21 (right to life or other fundamental rights guaranteed under the Constitution.
"There is no complete ban on cannabis under NDPS Act but can be used for medical, scientific, industrial, horticultural purposes by taking requisite permissions from respective State Governments," the affidavit filed by Director, Narcotics Control, Department of Revenue, Ministry of Finance said.
"The State governments are empowered to license the cultivation of cannabis for industrial and scientific purpose. On the similar lines, it may be inferred that the cultivation for industrial/ horticultural purposes, as provided in Section 14 of NDPS Act, can be considered by the State Government," it added.
While exercising this power, the State of Uttrakhand has allowed cultivation of hemp for industrial purposes and the hemp-based products are available in the market and also available online, the affidavit informed.
The Centre also submitted that cannabinoids are not a first-line treatment and cautioned against the "huge risk" of diversion of cannabis for non-medical use.
It highlighted that as per a survey by the Ministry of Social Justice & Empowerment, cannabis and opioids are the next commonly used substances in India, after alcohol and at the national level, one in eleven cannabis users suffered from cannabis dependence.
In its response, the Centre further clarified that under the NDPS Act, there was a "clear distinction between the various parts of cannabis plant, namely the fiber, flower and the seed and does not treat all of them and their derivative equally".
"The seeds and leave when not accompanied by the tops have not been included in the definition of cannabis. The Bhang which is an edible preparation of cannabis is also not controlled under the NDPS Act," it said.
The petitioner has sought to declare as unconstitutional the provisions in the NDPS Act and Rules which prohibit and criminalise the use of cannabis and prescribe unreasonable restrictions with respect to activities related to it.
The petitioner trust, registered in Karnataka and in the forefront of the movement to decriminalise the use of cannabis, has claimed there is not a single document which shows that it was lethal to humans and emphasises the use of cannabis was legal in several other countries.
Also Read:Recent cannabis use linked to extremes of nightly sleep duration
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.